Echolight provides Radiofrequency Echographic Multi Spectometry (REMS) technology, an ultrasound-based bone density scan that is an alternative to DXA scans. This technology is portable, with no lead-lined room required and is a better choice for pregnant patients as well as pediatric and oncology patients for monitoring bone health. See a demonstration in our booth.
Echolight is headquartered in Italy and in 2020, opened offices in the United States. In less than three years, Echolight built a sales network with more than 40 distributors and several hundreds of customers across the world who have adopted the innovative R.E.M.S. technology for assessing the bone condition of their patients using ultrasound technology.